90 related articles for article (PubMed ID: 1963681)
21. Localization of I-131-labeled goat and primate anti-carcinoembryonic antigen(CEA) antibodies in patients with cancer.
Sullivan DC; Silva JS; Cox CE; Haagensen DE; Harris CC; Briner WH; Wells SA
Invest Radiol; 1982; 17(4):350-5. PubMed ID: 6752092
[TBL] [Abstract][Full Text] [Related]
22. [Immunoscintigraphic follow-up studies with the 99m-Tc marked monoclonal anti-CEA antibody BW 431/26].
Fritzsche H
Acta Med Austriaca; 1990; 17(2-3):44-6. PubMed ID: 2220267
[TBL] [Abstract][Full Text] [Related]
23. [Xeroradiography of axillary lymph nodes in patients with tumors of the breast].
Nessi R; Balzarini L; Gilardoni L; Andreoli C; Costa A; Coopmans de Yoldi G
Radiol Med; 1983 May; 69(5):310-5. PubMed ID: 6318276
[TBL] [Abstract][Full Text] [Related]
24. 99mTc-anti-CEA radioimmunoscintigraphy of lung adenocarcinoma.
Leitha T; Walter R; Schlick W; Dudczak R
Chest; 1991 Jan; 99(1):14-9. PubMed ID: 1984945
[TBL] [Abstract][Full Text] [Related]
25. An observation of DNA ploidy, histological grade, and immunoreactivity for tumour-related antigens in primary and metastatic breast carcinoma.
Hitchcock A; Ellis IO; Robertson JF; Gilmour A; Bell J; Elston CW; Blamey RW
J Pathol; 1989 Oct; 159(2):129-34. PubMed ID: 2553906
[TBL] [Abstract][Full Text] [Related]
26. [Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment].
Ohsako T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1301-3. PubMed ID: 16969029
[TBL] [Abstract][Full Text] [Related]
27. [Retrosternal lymph node metastases in breast cancer: lymphoscintigraphy and magnetic resonance tomography].
Linden A; Reusch K; Smolarz K; Jungehülsing M; Theissen P; Bolte A; Schicha H
Nuklearmedizin; 1991 Dec; 30(6):279-82. PubMed ID: 1780241
[TBL] [Abstract][Full Text] [Related]
28. Radioimmunoimaging of metastatic medullary carcinoma of the thyroid gland using an indium-111-labeled monoclonal antibody to CEA.
Edington HD; Watson CG; Levine G; Tauxe WN; Yousem SA; Unger M; Kowal CD
Surgery; 1988 Dec; 104(6):1004-10. PubMed ID: 3194829
[TBL] [Abstract][Full Text] [Related]
29. [A comparison of 201Tl and 99mTc-MIBI in the follow-up of differentiated thyroid carcinomas].
Briele B; Hotze A; Kropp J; Bockisch A; Overbeck B; Grünwald F; Kaiser W; Biersack HJ
Nuklearmedizin; 1991 Aug; 30(4):115-24. PubMed ID: 1788076
[TBL] [Abstract][Full Text] [Related]
30. Thyroid metastases from a breast cancer diagnosed by fine-needle aspiration biopsy. Case report and overview of the literature.
Lacka K; Breborowicz D; Uliasz A; Teresiak M
Exp Oncol; 2012 Jul; 34(2):129-33. PubMed ID: 23013767
[TBL] [Abstract][Full Text] [Related]
31. The relationship between cytotoxicity and prognostically significant histologic changes in lymph nodes from patients with cancer of the breast.
Check IJ; Cobb M; Hunter RL
Am J Pathol; 1980 Feb; 98(2):325-38. PubMed ID: 6243870
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis of breast carcinoma with radiolabeled monoclonal antibodies (MoAbs) to carcinoembryonic antigen (CEA) and human milk fat globulin (HMFG).
Rosner D; Nabi H; Wild L; Ortman-Nabi J; Hreshchyshyn MM
Cancer Invest; 1995; 13(6):573-82. PubMed ID: 7583706
[TBL] [Abstract][Full Text] [Related]
33. [Evaluation of sentinel lymph node biopsy in detection of axillary lymph node metastasis in breast cancer].
Zhang JG; Zhong L; Li CL
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):235-6. PubMed ID: 17649646
[No Abstract] [Full Text] [Related]
34. Anti-CEA labelling kit BW 431/26. Results of the European multicenter trial.
Steinsträsser A; Oberhausen E
Nuklearmedizin; 1995 Dec; 34(6):232-42. PubMed ID: 8596740
[TBL] [Abstract][Full Text] [Related]
35. Synchronous metastasis from double primary cancers in a single left supraclavicular lymph node.
Kim YA; Min HS; Cho SW; Park YJ
Korean J Intern Med; 2017 Nov; 32(6):1121-1122. PubMed ID: 28992683
[No Abstract] [Full Text] [Related]
36. [Bilateral carcinoma of the breast].
Arcidiaco M; Valenti L; Pandolfi U; Uggeri G
Ann Ital Chir; 1984; 56(3):249-62. PubMed ID: 6099702
[No Abstract] [Full Text] [Related]
37. Immunoscintigraphy in medullary thyroid cancer using an 123I- or 111In-labelled monoclonal anti-CEA antibody fragment.
Reiners C; Eilles C; Spiegel W; Becker W; Börner W
Nuklearmedizin; 1986 Dec; 25(6):227-31. PubMed ID: 3808964
[TBL] [Abstract][Full Text] [Related]
38. Semiquantitative SPECT tumor uptake of technetium-99m-labeled anti-CEA monoclonal antibody in colorectal tumor.
Oriuchi N; Endo K; Watanabe N; Sugiyama S; Asao T; Takenoshita S; Nagamachi Y; Baum RP
J Nucl Med; 1995 Apr; 36(4):679-83. PubMed ID: 7699464
[TBL] [Abstract][Full Text] [Related]
39. Utility of intraoperative frozen section examination of sentinel lymph nodes in ductal carcinoma in situ of the breast.
Ballehaninna UK; Chamberlain RS
Clin Breast Cancer; 2013 Oct; 13(5):350-8. PubMed ID: 23791128
[TBL] [Abstract][Full Text] [Related]
40. Magnetic resonance imaging-guided occult breast lesion localization and simultaneous sentinel lymph node mapping.
de Lima Docema MF; Costa PA; de Andrade FE; Bevilacqua JL; Elias S; Cerri GG; Barros AC; Nazario AC
World J Surg Oncol; 2014 Oct; 12():320. PubMed ID: 25341393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
